HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Standardization, coordination needed to maximize lung cancer screening benefits
• Findings show reason to be ‘tremendously optimistic’ about treatment of pediatric low-grade gliomas Roger J. Packer, MD
• GI cancers symposium highlights targeted therapies, need for biomarker identification David H. Ilson, MD, PhD
• Majority of women report pain 1 year after breast cancer surgery
• Jacob, Bertino honored
• WHO projects ‘alarming rise’ in cancer worldwide
• Age, Gleason score, PSA indicate risk for prostate cancer overdiagnosis
• Sunitinib safe, effective in patients with mRCC, renal insufficiency
• TBK1 expression may represent marker for tamoxifen resistance in breast cancer
• HPV testing via self-collected samples showed usefulness
• Lymphopenia associated with RSV lower respiratory infection after cell transplant
• Bevacizumab, irinotecan combination effective in children with recurrent, low-grade glioma
• Cladribine induced long-term response in young patients with hairy cell leukemia
• Ganglioside GD2 potential therapeutic target in osteosarcoma
• Preoperative MRI for breast cancer did not reduce risk for local, distant recurrence
• Antifungal agent demonstrated activity in basal cell carcinoma
• Fine needle aspiration biopsy limits preoperative assessment in medullary thyroid cancer
• Preoperative chemotherapy failed to improve survival in oral cavity cancer
• Recombinant Factor IX Fc fusion protein reduced bleeding in hemophilia B
• Risk for thrombotic events may persist for 12 weeks after delivery
• Tumor staging finds most cSCC with positive SLNB occurred in T2 lesions
• Long-term aspirin use decreased risk for multiple myeloma
• One in five cancer trials fails to complete enrollment